Genpharmasec Statements
53
Genpharmasec Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
165.83
100
131.7
80.3
34.126
19.7
—
0
3.967
1.6
32.438
18.2
1.688
1.5
-2.667
-1.4
4.544
3.1
3.565
3.2
3.445
3.7
0.12
-0.5
0
507.4
138.23
100
110.62
84.4
27.605
15.6
—
0
3.675
2.2
27.867
16.1
-0.262
-0.5
-1.279
-0.8
2.642
1.9
1.101
0.6
0.759
0.5
0.34
0.1
0.001
461.08
126.22
100
111.14
85.4
15.078
14.6
—
0
3.525
2.7
10.905
11.4
4.173
3.2
-0.56
-0.9
0.767
0.9
4.38
3.3
-8.432
-13.6
12.812
16.8
0.034
337.29
128.94
100
122.77
94.1
6.166
5.9
—
0
1.842
1.6
7.902
4.9
-1.736
1.1
—
0
0.235
0
-1.501
1.1
—
0
-1.501
1.1
-0.007
213.5
141.99
100
134.73
98.1
7.256
1.9
—
0
1.607
1.3
7.263
4.7
-0.007
-2.8
—
0
0.272
0.2
0.265
-2.6
-2.337
-3.1
2.602
0.5
0.009
276.86
131.22
100
130.92
107.4
0.298
-7.4
—
0
1.014
1
5.646
6
-5.348
-13.4
—
0
0.653
0.1
-4.695
-13.3
—
-1.02
-4.695
-12.2
-0.017
276.86
91.759
100
61.454
58.2
30.305
41.8
—
0
0.998
0.7
4.161
2.2
26.144
39.5
—
0
0.281
-0.8
26.425
38.7
2.521
3.7
23.904
35
0.086
276.86
203.79
100
203.2
107.6
0.583
-7.6
—
0
1.232
0.7
7.189
4.2
-6.606
-11.8
—
0
4.685
2.5
-1.921
-9.3
—
0
-1.921
-9.3
-0.011
295.25
81.885
100
73.328
89.2
8.557
10.8
—
0
0.823
0.7
3.625
4
4.932
6.8
—
0
2.656
1.5
7.589
8.3
1.96
0.2
5.628
8.1
0.025
216.86
83.128
100
79.035
95.4
4.093
4.6
—
0
0.468
0.4
2.6
1.4
1.493
3.2
—
0
2.973
2.1
4.466
5.3
—
0
4.466
5.3
0.021
216.86